Skip to main content
SpringerLink
Log in

Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease

  • Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

A prospective study was carried out on 13 patients with ulcerative colitis and 11 with Crohn's disease to compare the value of radioimmunoscintigraphy involving99mTc-labeled antigranulocyte monoclonal antibody (BW 250/183) with that of hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy. The extent of the process (various segments of the small bowel; ascending, transverse, and descending colon; and rectosigmoideum) was determined in 115 segments by means of radioimmunoscintigraphy and leukocyte scintigraphy and compared with the results of enteroclysis and colonoscopy in 64 segments. The scintigraphic activity, calculated by summing the segment scores, was compared with clinical and laboratory parameters. During radioimmunoscintigraphy, the 24-hr fecal excretion of the antibody was measured. The two methods revealed a different extent of the process (P<0.01). The segmental sensitivity and specificity were 63% and 96% in radioimmunoscintigraphy, and 87% and 94% in leukocyte scintigraphy. Leukocyte scintigraphy proved to be superior in cases with small intestine involvement, but the methods are of similar value in cases with large bowel involvement. The scintigraphic activity determined by radioimmunoscintigraphy and the fecal excretion of monoclonal antibody correlated with seven parameters, while that determined by leukocyte scintigraphy did so with 12 variables. Both methods are of similar value for the detection of large bowel involvement, but leukocyte scintigraphy was the better method for determination of the involved segments in the small intestine. The scintigraphic activity proved a useful parameter, correlating well with the clinical and laboratory variables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sellink J, Miller R: Radiology of the Small Bowel: Modern Enteroclysis Technique and Others. Nijhoff, The Hague, 1982

    Google Scholar 

  2. Best WR, Becktel JM, Singelton JW, Kern F Jr: Development of a Crohn's disease activity index. Gastroenterology 70:439–444, 1976

    PubMed  Google Scholar 

  3. Segal AW, Munro JM, Ensell J, Sarner M: Indium-111 tagged leukocytes in the diagnosis of inflammatory bowel disease. Lancet II:230–232, 1981

    Google Scholar 

  4. Schölmerich J, Schmidt E, Schümichen C, Billman P, Schmidt H, Geroc W: Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium-99m hexamethyl propylene amine oxime as leukocyte label. Gastroenterology 95:1287–1293, 1988

    PubMed  Google Scholar 

  5. Seybold K, Locher JT, Coosemans C, Andres RY, Schubiger PA, Blauenstein P: Immunoscintigraphic localisation of inflammatory lesions: clinical experience. Eur J Nucl Med 13:587–593, 1988

    PubMed  Google Scholar 

  6. Segarra I, Roca M, Baliellas C, Vilar L, Ricart Y, Mora J, Puchal R, Martin-Comin J: Granulocyte-specific monoclonal antibody technetium-99-BW 250/183 and indium-111 oxine labeled leukocyte scintigraphy in inflammatory bowel disease. Eur J Nucl Med 18:715–719, 1991

    PubMed  Google Scholar 

  7. Solanki KK, Mather SJ, Janabi MA, Britton KE: A rapid method for the preparation of 99Tcm hexametazime-labeled leucocytes. Nucl Med Commun 9:753–761, 1988

    PubMed  Google Scholar 

  8. Ballinger JR, Reid RM, Gullenchyn KY: Radiochemical purity of 99mTc-HMPAO. J Nucl Med 29:572–573, 1988

    PubMed  Google Scholar 

  9. Thakur ML, Lavender JP, Arnot RN, Silvester DJ, Segal AW: 111-In labeled autologous leukocytes in man. J Nucl Med 18:1012–1019, 1977

    Google Scholar 

  10. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, Kelly JD, Neirinckx RD, Lavender JP: Clinical experience with 99mTc-hexamethylpropyleneaminoxime for labeling leukocytes imaging inflammation. Lancet II:946–949, 1986

    Google Scholar 

  11. Stein DT, Gray GM, Gregory PB, Anderson M, Goodwin DA, McDougall IR: Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. Gastroenterology 84:388–393, 1983

    PubMed  Google Scholar 

  12. Crama-Bochbouth GE, Pena AS, Arndt JW, Tjon RTO, Tham A, Verspaget HW, Weterman IT, Pauwels EKJ, Lamers CBHW: Value of indium-111 tropolonate autologous granulocyte scintigraphy in assessment of inflammatory bowel disease. Scand J Gastroenterol 25(suppl 178):93–98, 1990

    Google Scholar 

  13. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS: Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Gastroenterology 90:1121–1128, 1986

    PubMed  Google Scholar 

  14. Almer L, Franzén L, Peters AM, Tjadermo M, Ekberg S, Granerus G, Ström M: Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 27:1031–1038, 1992

    PubMed  Google Scholar 

  15. Lantto E, Jarvi K, Krekela I, Lantto T, Taavitsainen M, Vedenkangas H, Vorne M: Technetium-99-m hexamethyl propylene amine oxine leukocytes in the assessment of disease activity in inflammatory bowel diseases. Eur J Nucl Med 19:14–18, 1992

    PubMed  Google Scholar 

  16. Allen RA, Sladen GE, Bassingham S, Lazarus C, Clarke SEM, Fogelman I: Comparison of simultaneous99mTc-HMPAO and111In oxine labeled white cell scans in the assessment of inflammatory bowel disease. Eur J Nucl Med 20:195–200, 1993

    PubMed  Google Scholar 

  17. Arndt JW, van der Sluys Veer A, Blok D, Griffioen G, Verspaget HV, Lamers CBHW Pauwels EKJ: Prospective comparative study of technetium-99m WBCs and indium-111-granulocytes for examination of patients with inflammatory bowel disease. J Nucl Med 34:1052–1057, 1993

    PubMed  Google Scholar 

  18. Gibson P, Lichtenstein M, Salehi N, Hebbard G, Andrews J: Value of positive technetium-99m leukocyte scans in predicting intestinal inflammation. Gut 32:1502–1507, 1991

    PubMed  Google Scholar 

  19. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W: Radiolabeled granulocytes in inflammatory bowel disease: Diagnostic possibilities and clinical indications. Nucl Med Commun 9:693–701, 1988

    PubMed  Google Scholar 

  20. Weeler JG, Slack NF, Duncan A, Palmer M, Harvey RF:99Tcm-nanocolloid imaging in inflammatory bowel disease. Nucl Med Commun 11:127–133, 1990

    PubMed  Google Scholar 

  21. Arndt JW, van der Sluys Veer A, Blok D, Griffioen G, Verspaget HV, Pena AS, Lamers CBHW Pauwels EKJ: A prospective comparison of 99m-Tc-labeled polyclonal human immunoglobulin and 111-In granulocytes for localization of inflammatory bowel disease. Acta Radiol 33:140–144, 1992

    PubMed  Google Scholar 

  22. Buchegger F, Schreyer M, Carel S, Mach J-P: Monoclonal Antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenivity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer 33:643–649, 1984

    PubMed  Google Scholar 

  23. Lind P, Langsteger W, Költringer P, Dimai HP, Passl R, Eber O: Immunoscintigraphy of inflammatory process with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med 31:417–423, 1990

    PubMed  Google Scholar 

  24. Mahida YR, Perkins AC, Frier M, Wastie ML, Hawkey CJ: Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun 13:330–335, 1992

    PubMed  Google Scholar 

  25. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P: Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: Diagnostic and clinical relevance. Gut 34:1364–1369, 1993

    PubMed  Google Scholar 

  26. Ivancevic V, Munz DL: Nonspecific bowel activity in99Tcm-labeled monoclonal anti-granulocyte antibody imaging. Nucl Med Commun 13:899–900, 1992

    PubMed  Google Scholar 

  27. Joseph K, Höffken H, Bosslet K, Schorlemmer HU: Imaging of inflammation with granulocytes labeledin vivo. Nucl Med Commun 9:763–769, 1988

    PubMed  Google Scholar 

  28. Perkins AC, Frier M, Mahida YR, Wastie ML, Baum RP:99Tcm-antigranulocyte-antibody in the detection of inflammatory bowel disease. Nucl Med Commun 12:263, 1991 (abstract)

    Google Scholar 

  29. Becker WS, Saptogino A, Wolf FG: The single late99Tcm granulocyte antibody scan in inflammatory disease. Nucl Med Commun 13:186–192, 1992

    PubMed  Google Scholar 

  30. Shawler DL, Bartholomew RM, Smith LM, Dillman RO: Human immune response to multiple injections of murine monoclonal IgG. J Immunol 135:1530–1535, 1985

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Nuclear Medicine, Albert Szent-Györgyi Medical University, and County Hospital, Szeged, Hungary

    Miklós Papós MD, Ferenc Nagy MD, György Nárai MD, Mária Rajtár PhD, Gábor Szántai MD, Jenö Láng PhD & László Csernay PhD, DSc

Authors
  1. Miklós Papós MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ferenc Nagy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. György Nárai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mária Rajtár PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gábor Szántai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jenö Láng PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. László Csernay PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papós, M., Nagy, F., Nárai, G. et al. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Digest Dis Sci 41, 412–420 (1996). https://doi.org/10.1007/BF02093837

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02093837

Key words

Search

Navigation